Makoto Kida
About Makoto Kida
Makoto Kida is the Head of Risk Management for World Wide Patient Safety Japan at Bristol Myers Squibb, with over 20 years of experience in the pharmaceutical industry, focusing on medical affairs and product management.
Title
Makoto Kida is the Head of Risk Management, World Wide Patient Safety Japan at Bristol Myers Squibb. He is currently based in Tokyo.
Career at Bristol Myers Squibb
Makoto Kida has built a prolific career at Bristol Myers Squibb. Since 2014, he has held multiple leadership roles, including Head of Cardiovascular Therapeutic Area, Manager of Medical Strategy Lead, and Head of Cardiovascular Medical. He was the Senior Director and Head of the Japan, Korea, and Taiwan Medical Capabilities from 2017 to 2018. Between 2019 and 2021, he was the Senior Director and Head of Oncology 1 Medical Unit.
Previous Roles at Sanofi
Before joining Bristol Myers Squibb, Makoto Kida worked at Sanofi, where he served as a Product Manager from 2006 to 2011 and later as a Senior Product Manager from 2012 to 2013.
Early Career Experience
Makoto Kida started his career in the pharmaceutical industry at Dainippon Sumitomo Pharma in 1995 as a Hospital and GP Sales Representative. He later moved to Eli Lilly and Company, where he worked as Team Leader, CNS Sales Representative from 2002 to 2005.
Educational Background
Makoto Kida has a comprehensive educational background. He obtained his Master of Business Administration (MBA) from GLOBIS University - Graduate School of Management. He also studied at the Department of Animal Science and Resources at Nihon University. Additionally, he completed the CUMOT (Management of Technology) program at Tokyo Institute of Technology.